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Identity 
Alias: Wilms tumour 
Clinics and pathology 
Etiology 
- Wilms tumours are either sporadic or familial (1-
2%); it may be associated with hemihypertrophia or 
genitourinary malformations (10%) and part of a 
recognized syndrome (2%).  
- The syndromes predisposing to Wilms tumours 
are: WAGR (Wilms tumour, aniridia, genitourinary 
abnormalities and mental retardation), DDS 
(Denys-Drash syndrome: mesangial sclerosis, male 
pseudohermaphrodism and Wilms tumours), BWS 
(Beckwith-Weideman: exomphalos, macroglossia, 
gigantism) and SGBS (Simpson Golabi Behmel 
syndrome: overgrowth, mental impairment, 
craniofacial anomalies). 
Epidemiology 
The most common paediatric cancer of the kidney, 
affecting 10/105 children; 50% of cases occurs 
before the age of 3 years and 90% before 6 years. 
Clinics 
The localization is primarily the kidney; the 
incidence of bilateral involvement is 5-10%. 
Pathology 
Wilms tumours show a mimicry of nephrogenesis 
as the tumour comprises undifferentiated blastemal 
cells, differentiated epithelial cells and stromal 
cells; ectopic components, particularly skeletal 
muscle, are observed in 5-10% of tumours; the 
presence of identical deletions of WT1 in all 
components of some sporadic Wilms tumours 
suggests that the stromal components are 
neoplastic, raising the possibility that 
undifferentiated blastema cells are precursors of the 
stromal and heterologous elements. 
Treatment 
Stage 1 and 2 are treated with nephrectomy and 
chemotherapy, radiation therapy is added to 
tumours of higher staging. 
Prognosis 
The overall cure rate for unilateral Wilms tumours 




This entity is heterogenous at the genetic level. 
Cytogenetics 
Cytogenetics Morphological 
The observed heterogeneity reflects the complexity 
of the genetic changes; structural changes at 11p13, 
11p15, 1p, 1q and 7p are the most frequently 
reported, as well as trisomies 8, 12, and 18; 11p 
deletions occur in 20% of cases, trisomy 12 in 25%, 
del(16q) in 20%; the der(16)t(1;16), also described 
in a wide range of tumours, is considered a marker 
of tumour progression. 
Genes involved and 
proteins 
Note 
- 11p13: constitutional deletion of one copy of the 
WT1 gene (11p13) is responsible for predisposition 
to Wilms tumours and for genitourinary 
malformations in WAGR patients; constitutional 
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heterozygous intragenic mutations have been 
described in DDS; WT1 is somatically involved in 
10% of the sporadic cases. 
- 11p15: BWS, an overgrowth syndrome, is caused 
by alterations of 11p15, a region subject to genomic 
imprinting: loss of of imprinting of IGF2 is the 
most common defect found; WT1 is rarely 
implicated solely in sporadic Wilms tumours, but 
maternal alleles often displays a loss of 
heterozygosity (LOH) at 11p15, which suggests the 
existence of a second locus WT2.  
- 7p, 17q, 19q: a third locus WT3, at least, is likely, 
on the grounds of the existence of familial cases of 
Wilms tumour without 11p13 nor 11p15 
involvement; one locus has been identified in 17q 
in one large Wilms tumours family, and another 
one in 19q13 in five families; another predisposing 
gene to Wilms tumours maps to 7p, where 
constitutional translocations and somatic deletions 
have been described; in tumours, loss of 
heterozygosity for 16q has been reported for two 
different loci: 16q13 and 16q21. 
- Xq26: the gene of SGBS, an overgrowth 
syndrome, has been cloned at Xq26. 
- Mutations of P53 occur in 5% of Wilms tumours 




DNA / RNA 
50 kb, 10 exons. 
Protein 
Protein tumour zing finger transcription factor 
expressed during renal and gonadal development; 
exons 1-6 encode a proline/glutamine rich 
transcriptional regulation region; exons 7-10 
encode the four zinc fingers; two alternative 
splicing regions allow synthesis of four isoforms 
showing different binding specificity; WT1 
regulates transcription of several genes, including 
IGF2 and PDGFA; the WT1-KTS isoforms 
associate and synergize with SF-1 (steroidogenic 
factor 1) to promote AMH (anti mullerian hormone 
or MIS, mullerian inhibiting substance). 
Germinal mutations 
Missense mutations of exons 8 and 9 in DDS; in the 
proximal part of the gene leading to truncated 
proteins in WAGR, genitourinary malformations 
and WT; in the donor splice site of intron 9 in 
Frasier syndrome (pseudohermaphroditism, 
glomerulopathy, not associated WT). 
Somatic mutations 
Stop and frameshift mutations in about 10% of WT. 
References 
Austruy E, Candon S, Henry I, Gyapay G, Tournade MF, 
Mannens M, Callen D, Junien C, Jeanpierre C. 
Characterization of regions of chromosomes 12 and 16 
involved in nephroblastoma tumorigenesis. Genes 
Chromosomes Cancer. 1995 Dec;14(4):285-94 
Little M, Wells C. A clinical overview of WT1 gene 
mutations. Hum Mutat. 1997;9(3):209-25 
Soukup S, Gotwals B, Blough R, Lampkin B. Wilms tumor: 
summary of 54 cytogenetic analyses. Cancer Genet 
Cytogenet. 1997 Sep;97(2):169-71 
Zhuang Z, Merino MJ, Vortmeyer AO, Bryant B, Lash AE, 
Wang C, Deavers MT, Shelton WF, Kapur S, Chandra RS. 
Identical genetic changes in different histologic 
components of Wilms' tumors. J Natl Cancer Inst. 1997 
Aug 6;89(15):1148-52 
Jeanpierre C, Béroud C, Niaudet P, Junien C. Software 
and database for the analysis of mutations in the human 
WT1 gene. Nucleic Acids Res. 1998 Jan 1;26(1):271-4 
McDonald JM, Douglass EC, Fisher R, Geiser CF, Krill CE, 
Strong LC, Virshup D, Huff V. Linkage of familial Wilms' 
tumor predisposition to chromosome 19 and a two-locus 
model for the etiology of familial tumors. Cancer Res. 1998 
Apr 1;58(7):1387-90 
This article should be referenced as such: 
Miozzo M. Kidney: Nephroblastoma (Wilms tumor). Atlas 
Genet Cytogenet Oncol Haematol. 1999; 3(1):41-42. 
